XPNPEP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.611850E-01
Normal-vs-Stage2
2.893800E-01
Normal-vs-Stage3
7.346800E-01
Normal-vs-Stage4
1.661830E-01
Stage1-vs-Stage2
4.834200E-01
Stage1-vs-Stage3
2.185800E-01
Stage1-vs-Stage4
9.456800E-01
Stage2-vs-Stage3
3.794600E-01
Stage2-vs-Stage4
5.104200E-01
Stage3-vs-Stage4
2.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.841400E-01
Normal-vs-AfricanAmerican
6.710500E-02
Normal-vs-Asian
4.868000E-01
Caucasian-vs-AfricanAmerican
1.567630E-01
Caucasian-vs-Asian
4.768200E-01
AfricanAmerican-vs-Asian
1.001410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.806400E-01
Normal-vs-Female
2.606200E-01
Male-vs-Female
8.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.699400E-01
Normal-vs-Age(41-60Yrs)
1.876840E-01
Normal-vs-Age(61-80Yrs)
3.159800E-01
Normal-vs-Age(81-100Yrs)
2.324400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.789760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.052800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.216400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.272400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.897200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.966200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.046400E-01
Normal-vs-Daily Drinker
8.056800E-01
Normal-vs-Weekly Drinker
3.931400E-01
Normal-vs-Occasional Drinker
2.216200E-01
Normal-vs-Social Drinker
1.291370E-01
Non Drinker-vs-Daily Drinker
2.555200E-01
Non Drinker-vs-Weekly Drinker
4.308000E-01
Non Drinker-vs-Occasional Drinker
1.223190E-01
Non Drinker-vs-Social Drinker
2.730200E-02
Daily Drinker-vs-Weekly Drinker
1.483390E-01
Daily Drinker-vs-Occasional Drinker
2.964200E-02
Daily Drinker-vs-Social Drinker
7.016800E-03
Weekly Drinker-vs-Occasional Drinker
6.474000E-01
Weekly Drinker-vs-Social Drinker
3.455600E-01
Occasional Drinker-vs-Social Drinker
5.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.745190E-01
Normal-vs-Grade 2
5.886000E-02
Normal-vs-Grade 3
7.395500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.676000E-01
Grade 1-vs-Grade 3
3.859400E-01
Grade 1-vs-Grade 4
1.745190E-01
Grade 2-vs-Grade 3
3.414000E-01
Grade 2-vs-Grade 4
5.886000E-02
Grade 3-vs-Grade 4
7.395500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.542000E-01
Normal-vs-NonDiabetic
2.820200E-01
Diabetic-vs-NonDiabetic
1.341370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.966020E-01
Normal-vs-NoPancreatitis
3.369000E-01
Pancreatitis-vs-NoPancreatitis
6.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.024400E-01
Normal-vs-N1
2.955400E-01
N0-vs-N1
1.130640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.183000E-01
Normal-vs-TP53-NonMutant
2.376800E-01
TP53-Mutant-vs-TP53-NonMutant
6.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
